BusinessStock Market

Natco Pharma shares up 9% as it starts trials for COVID-19 drugs

2 Mins read
Natco pharma
  • Natco Pharma share price hits 20 percent upper circuit at Rs 1,188.95 apiece, also its all-time high, in intraday on BSE, after the corporate initiated clinical test |phase III|clinical trial|clinical test"> phase III clinical trial to gauge the efficacy and safety of Molnupiravir capsules in mild COVID-19 patients.
Get the latest updates by subscribing to us

Subscribe to us for getting the benefits of climbstreet and latest updates

Leave a Reply

Your email address will not be published. Required fields are marked *